Companies: 10,795·Total market cap: $144.5T
Rallybio Corporation

Rallybio Corporation

RLYBNASDAQHealthcare● Active
$15.91
$-0.04(-0.25%)
Market Cap$84293407
P/E Ratio
52W High$17.574
52W Low$2.4

Rallybio Corporation(RLYB)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · RLYB · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.86M$0.64M$0.00M$0.00M$0.00M
Cost of Revenue$0.09M$0.00M$0.15M$0.17M$0.11M
Gross Profit$0.77M$0.64M($0.15M)($0.17M)($0.11M)
Gross Margin %(computed)89.28%100.00%
Operating Expenses
R&D Expenses$19.60M$41.51M$53.54M$40.69M$26.91M
G&A Expenses$14.32M$19.63M$25.39M$27.20M$18.74M
Total Operating Expenses$28.83M$61.13M$78.93M$67.88M$45.65M
Operating Income($28.06M)($60.50M)($78.93M)($67.88M)($45.65M)
Operating Margin %(computed)
Interest Income$2.19M$4.22M$6.15M$1.96M$0.05M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.01M
Income Before Tax($8.98M)($57.77M)($74.56M)($67.73M)($47.01M)
Income Tax Expense$0.00M$0.00M$0.00M($1.07M)$0.00M
Net Income($8.98M)($57.77M)($74.56M)($66.65M)($47.01M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-1.59$-10.64$-14.72$-16.72$-11.68
Wtd Avg Shares5.63M5.44M5.06M3.98M4.02M
EBITDA($27.97M)($60.37M)($78.78M)($67.72M)($45.39M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Rallybio Corporation

关于Rallybio Corporation(RLYB)损益表

Rallybio Corporation(RLYB)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,RLYB实现营收$0.00B,毛利润$0.00B(毛利率89.28%),净利润($0.01B)(净利率-1046.39%)。

常见问题

RLYB · 4 问

Rallybio Corporation(RLYB)2025财年营收为$0.00B,同比up34.9%。

RLYB revenueRLYB salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09